Evaluation of rapid molecular methods for detection of clarithromycin resistance in Helicobacter pylori

European Journal of Clinical Microbiology and Infectious Diseases

Volumn 16, Issue 2, 1997, Pages 162-164

  Szczebara, F ^a   Dhaenens, L ^a   Vincent, P ^a   Husson, M O ^a  

^a UNIV LILLE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CLARITHROMYCIN; RIBOSOME RNA;

ANTIBIOTIC RESISTANCE; ARTICLE; CONTROLLED STUDY; HELICOBACTER PYLORI; MINIMUM INHIBITORY CONCENTRATION; MOLECULAR BIOLOGY; NONHUMAN; POINT MUTATION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; RESTRICTION SITE;

EID: 0031003872     PISSN: 09349723     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF01709478     Document Type: Article

References (14)

1. Tursi A, Cammarota G, Papa A, Montalto M, Fedeli G, Gasbarrini G: Short-term low-dose triple therapy with lansoprazole plus amoxicillin and clarithromycin for Helicobacter pylori eradication. American Journal of Gastroenterology 1996, 91: 1668-1670.
2. Cayla R, Zerbib F, Talbi P, Mégraud F, Lamouliatte H: Pre-and post-treatment clarithromycin resistance of Helicobacter pylori strains: a key factor of treatment failure. Gut 1995, 37, Supplement 1: A55.
3. Mégraud F: Helicobacter pylori resistance to antibiotics. In: Hunt RH, Tytgat GNJ (ed): Helicobacter pylori: basic mechanisms to clinical cure. Kluwer, Dordrecht, 1993, p. 570-583.
4. Godard AF, Logan RPH: Antimicrobial resistance and Helicobacter pylori. Journal of Antimicrobial Chemotherapy 1996, 37: 639-643.
5. European Study Group on Antibiotic Susceptibility of Helicobacter pylori: Results of a multicentre European survey in 1991 of metronidazole resistance in Helicobacter pylori. European Journal of Clinical Microbiology & Infectious Diseases 1992, 9: 777-781.
6. Henriksen TH, Brorson Ö, Schöyen R, Thoresen T: Risks related to lack of standardization of tests to detect in vitro metronidazole resistance in Helicobacter pylori. European Journal of Clinical Microbiology & Infectious Diseases 1996, 15: 484-488.
7. Ettayebi M, Prasad SM, Morgan EA: Chloramphenicol-erythromycin resistance mutations in a 23S rRNA gene of Escherichia coli. Journal of Bacteriology 1985, 162: 551-557.
8. Meier A, Kirschner P, Springer B, Steingrube VA, Brown BA, Wallace RJ, Bottger EC: Identification of mutations in 23S rRNA gene of clarithromycin resistant Mycobacterium intracellulare. Antimicrobial Agents and Chemotherapy 1994, 38: 381-384.
9. Weisblum B: Erythromycin resistance by ribosome modification. Antimicrobial Agents and Chemotherapy 1995, 39: 577-585.
10. Skinner R, Cundiffe E, Schmidt FJ: Site of action of a ribosomal RNA methylase responsible for resistance to erythromycin and other antibiotics. Journal of Biological Chemistry 1983, 258: 12702-12706.
11. Versalovic J, Shortridge D, Kibler K, Griffy M, Beyer J, Flamm RK, Tanaka K, Graham DY, Go MF: Mutations in 23S rRNA are associated with clarithromycin resistance in Helicobacter pylori. Antimicrobial Agents and Chemotherapy 1996, 40: 477-480.
12. National Committee for Clinical Laboratory Standards: Methods for antimicrobial susceptibility testing of anaerobic bacteria. Approved Standard M11-A2. NCCLS, Villanova, PA, 1990.
13. Hachem CY, Clarridge JE, Reddy R, Flamm R, Evans DG, Tanaka SK: Antimicrobial susceptibility testing Helicobacter pylori. Comparison of E test, broth microdilution, and disk diffusion for ampicillin, clarithromycin, and metronidazole. Diagnostic Microbiology and Infectious Diseases 1996, 24: 570-583.
14. Xia HX, Buckley M, Keane CT, O'Morain CA: Clarithromycin resistance in Helicobacter pylori: prevalence in untreated dyspeptic patients and stability in vitro. Journal of Antimicrobial Chemotherapy 1996, 37: 473-481.